WHITTLESEY PHARMACY LIMITED

Company Registration Number:
07309063 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2023

Period of accounts

Start date: 01 August 2022

End date: 31 July 2023

WHITTLESEY PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2023

Balance sheet
Notes

WHITTLESEY PHARMACY LIMITED

Balance sheet

As at 31 July 2023


Notes

2023

2022


£

£
Fixed assets
Intangible assets: 3 170,000 180,000
Tangible assets: 4 48,292 47,688
Total fixed assets: 218,292 227,688
Current assets
Stocks: 98,850 83,495
Debtors:   660,068 788,334
Cash at bank and in hand: 443,630 689,065
Total current assets: 1,202,548 1,560,894
Creditors: amounts falling due within one year:   (191,998) (598,399)
Net current assets (liabilities): 1,010,550 962,495
Total assets less current liabilities: 1,228,842 1,190,183
Total net assets (liabilities): 1,228,842 1,190,183
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 1,227,842 1,189,183
Shareholders funds: 1,228,842 1,190,183

The notes form part of these financial statements

WHITTLESEY PHARMACY LIMITED

Balance sheet statements

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 05 September 2023
and signed on behalf of the board by:

Name: Simon Yacoub
Status: Director

The notes form part of these financial statements

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

2. Employees

2023 2022
Average number of employees during the period 8 7

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

3. Intangible Assets

Total
Cost £
At 01 August 2022 200,000
At 31 July 2023 200,000
Amortisation
At 01 August 2022 20,000
Charge for year 10,000
At 31 July 2023 30,000
Net book value
At 31 July 2023 170,000
At 31 July 2022 180,000

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

4. Tangible Assets

Total
Cost £
At 01 August 2022 77,922
Additions 6,630
At 31 July 2023 84,552
Depreciation
At 01 August 2022 30,234
Charge for year 6,026
At 31 July 2023 36,260
Net book value
At 31 July 2023 48,292
At 31 July 2022 47,688

WHITTLESEY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

5. Related party transactions

Name of the related party: No Ordinary locum Agent Limited
Relationship:
Director
Description of the Transaction: "The transaction was the loan of an asset".
£
Balance at 01 August 2022 40,372
Balance at 31 July 2023 52,000
Name of the related party: Clockpad limited
Relationship:
Director
Description of the Transaction: The transaction was the loan of an asset".
£
Balance at 01 August 2022 24,000
Balance at 31 July 2023 24,000
Name of the related party: Vakani Investments Limited
Relationship:
Director
Description of the Transaction: "The transaction was the loan of an asset".
£
Balance at 01 August 2022 240,000
Balance at 31 July 2023 240,000